MicroRNA biomarkers could provide advance warning of heart attack

Heart attacks could in future be predicted days in advance using a wearable blood monitor, new research suggests.

Scientists have identified two biomarkers whose levels drop dramatically within two weeks of a heart attack.

The biomarkers studied for the research are microRNAs, small strands of genetic material that are able to switch off genes by interfering with the way their codes are translated.

The scientists believe that, when present, the microRNAs help to prevent heart attacks happening by blocking some unknown cardiac process.

Dr Galenko said: “MicroRNAs turn things off. Whatever they usually turn off in people with heart disease before a heart attack isn’t being turned off when microRNA levels are reduced, which may be causing something else to be activated.

“MicroRNAs act like a watchdog, and when their levels are reduced, heart disease takes a turn for the worse and heart attacks are likely to occur.”

Read the full, original story: First step towards a heart attack ‘alarm’

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
Discarded Green Cap on Public Trash Can
'Blatant slap in the face': MAHA activists turn on RFK Jr. and Trump administration
newborn baby spit up gerd
Vaccine-preventable congenital infections are a leading driver of autism
Screenshot 2026-10-16 at 11.17
Viewpoint: Latest attack on renewable energy and farmers, new USDA rules could put solar grants out of reach for small producers
Government Briefing on Autism Trends
Viewpoint: ‘Statistical murder’: Kennedy’s expanding record of “duplicity and mendacity”
FDA Vials and Syringes Flat Lay
Online gold rush of unapproved peptides is outrunning federal regulators
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-15-at-9.51.15-AM
 Viewpoint: Selective pronatalism: The radical “ethical” case challenging parents’ right to end a pregnancy when a fetus has a severe genetic disorder
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Screenshot-2026-10-15-at-12.13.33-PM
Ahead of the midterms, Meta has paid at least 29 anti-LGBTQ accounts for their posts
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.